Find paid trials
Partner with us

Healthy Participants

The Strong Gut Study Part 2

  • Start date

    Sep 24th, 29th, Oct 14th, 15th
  • Renumeration

    $9450

3 night stay + 1 night + 1 night, 11 follow ups

Help Test a New Potential drug for the Treatment of IBD

This clinical study is evaluating a potential new drug to treat IBD. IBD is a term used to describe conditions that cause abdominal pain and diarrhoea, among other symptoms.

The study drug is designed to reduce the inflammatory response that causes IBD symptoms. 

The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–35.

Apply Now

Schedule

Cohort 1.1

  • 3 Night Stay

Check In

Sep 24th

Check Out

Sep 27th

  • (No Appointment)

(No Check In Date)

-

  • 1 Night Stay

Check In

Oct 09th

Check Out

Oct 10th

  • (No Appointment)

(No Check In Date)

-

  • 1 Night Stay

Check In

Oct 23rd

Check Out

Oct 24th

  • 11 appointments

Oct 02nd, 16th, 30th, Nov 06th, 13th, 20th, Dec 04th, 18th, Jan 15th, Feb 12th, Mar 12th

Cohort 1.2

  • 3 Night Stay

Check In

Sep 29th

Check Out

Oct 02nd

  • (No Appointment)

(No Check In Date)

-

  • 1 Night Stay

Check In

Oct 14th

Check Out

Oct 15th

  • (No Appointment)

(No Check In Date)

-

  • 1 Night Stay

Check In

Oct 28th

Check Out

Oct 29th

  • 11 appointments

Oct 07th, 21st, Nov 04th, 11th, 18th, 25th, Dec 09th, 23rd, Jan 20th, Feb 17th, Mar 17th

To Qualify, You Must

  • Age

    Be 18 to 55 years old
  • Gender

    Both males or females
  • Physical Condition
    Have no significant medical conditions
  • Requirements
    Have a BMI between 18 and 35kg/m2
  • Research Location
    Joondalup Early Phase Clinic

New healthy volunteer study coming soon.

Spots are limited. Find out if you qualify today!
 
Apply Now